CELLEX CORP has a total of 11 patent applications. Its first patent ever was published in 2004. It filed its patents most often in China, WIPO (World Intellectual Property Organization) and Japan. Its main competitors in its focus markets biotechnology and pharmaceuticals are SYMBIOCELLTECH LLC, GENEIUS BIOTECHNOLOGY INC and WEIDONG ZHANG.
# | Country | Total Patents | |
---|---|---|---|
#1 | China | 4 | |
#2 | WIPO (World Intellectual Property Organization) | 4 | |
#3 | Japan | 1 | |
#4 | Singapore | 1 | |
#5 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations | |
#4 | Microbiology |
# | Name | Total Patents |
---|---|---|
#1 | Masuyama Junichi | 7 |
#2 | Masuyama Jun-Ichi | 2 |
#3 | Fujita Sanehiko | 2 |
#4 | Fujita Jitsuhiko | 1 |
#5 | Jun-Ichi Masuyama | 1 |
#6 | Junichi Masuyama | 1 |
Publication | Filing date | Title |
---|---|---|
US2017137784A1 | NK Cell Culture Container And NK Cell Culture Method | |
CN105688205A | Cancer incidence inhibitor, antibody production ability reinforcing agent and hepatitis therapeutic agent | |
CN103429248A | Cancer inhibiting agent, antibody production enhancing agent, and therapeutic agent for hepatitis | |
CN102634484A | Natural killer (NK) cell activation method, NK cell proliferation method using same, NK cell preparation method and mononuclear cell containing NK cell | |
JP2011001315A | Immunotherapy agent for pancreatic cancer | |
WO2005033301A1 | Cell activation method and cell production method and medicinal composition using the same |